Agata Bielecka-Dabrowa1, Agata Sakowicz2, Małgorzata Misztal3, Stephan von Haehling4, Ali Ahmed5, Tadeusz Pietrucha2, Jacek Rysz6, Maciej Banach7. 1. Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland. Electronic address: agatbiel7@poczta.onet.pl. 2. Department of Medical Biotechnology, Medical University of Lodz, Poland. 3. Chair of Statistical Methods, Faculty of Economics and Sociology, University of Lodz, Poland. 4. Innovative Clinical Trials, Department of Cardiology and Pneumology, University Medicine Göttingen (UMG), Göttingen, Germany. 5. Department of Medicine Division of Gerontology, Geriatrics and Palliative Care, University of Washington, USA. 6. Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland. 7. Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.
Abstract
BACKGROUND/ OBJECTIVES: To evaluate whether biomarkers reflecting pathophysiological pathways and selected single nucleotide polymorphisms differ between patients (pts) with heart failure (HF). METHODS: 110 pts with were involved, including HF pts with preserved ejection fraction (HFpEF, n=51) with hypertensive origin, HF pts with reduced ejection fraction (HFrEF) with ischemic aetiology (ICM) (n=32) and HFrEF with dilated cardiomyopathy (DCM) (n=27). We assessed selected HF biomarkers, echocardiographic examinations and functional polymorphisms selected from six candidate genes: CYP27B1, NOS3, IL-6, TGF beta, TNF alpha, and PPAR gamma. RESULTS: Higher concentrations of TNF alpha were observed in pts with hypertensive HFpEF compared to pts with DCM (p=0.008). Pts with HFpEF had higher concentrations of TGF beta 1 compared to DCM and ICM (p=0.0001 and p=0.0003, respectively). For the NOS3 -786 C/T rs2070744 polymorphism in DCM there were significantly more CT heterozygotes than in ICM and HFpEF. In multivariate analysis TGF beta 1 (p=0.001) and syndecan 4 (p=0.001) were the only factors distinguishing HFrEF pts with DCM vs HFpEF and also TGF beta 1 (p=0.001) and syndecan 4 (p=0.023) were the only factors distinguishing HFrEF pts with ICM vs HFpEF pts. CONCLUSIONS: Inflammation mediated through TNF alpha and TGF beta 1 may represent an important component of an inflammatory response that partially drives the pathophysiology of HFpEF. NOS3 -786 C/T rs2070744 polymorphism in DCM may serve as a marker for more rapid progression of heart failure. The only biomarkers independently distinguishing HFpEF and HFrEF are syndecan 4 and TGF beta 1.
BACKGROUND/ OBJECTIVES: To evaluate whether biomarkers reflecting pathophysiological pathways and selected single nucleotide polymorphisms differ between patients (pts) with heart failure (HF). METHODS: 110 pts with were involved, including HF pts with preserved ejection fraction (HFpEF, n=51) with hypertensive origin, HF pts with reduced ejection fraction (HFrEF) with ischemic aetiology (ICM) (n=32) and HFrEF with dilated cardiomyopathy (DCM) (n=27). We assessed selected HF biomarkers, echocardiographic examinations and functional polymorphisms selected from six candidate genes: CYP27B1, NOS3, IL-6, TGF beta, TNF alpha, and PPAR gamma. RESULTS: Higher concentrations of TNF alpha were observed in pts with hypertensive HFpEF compared to pts with DCM (p=0.008). Pts with HFpEF had higher concentrations of TGF beta 1 compared to DCM and ICM (p=0.0001 and p=0.0003, respectively). For the NOS3 -786 C/T rs2070744 polymorphism in DCM there were significantly more CT heterozygotes than in ICM and HFpEF. In multivariate analysis TGF beta 1 (p=0.001) and syndecan 4 (p=0.001) were the only factors distinguishing HFrEF pts with DCM vs HFpEF and also TGF beta 1 (p=0.001) and syndecan 4 (p=0.023) were the only factors distinguishing HFrEF pts with ICM vs HFpEF pts. CONCLUSIONS: Inflammation mediated through TNF alpha and TGF beta 1 may represent an important component of an inflammatory response that partially drives the pathophysiology of HFpEF. NOS3 -786 C/T rs2070744 polymorphism in DCM may serve as a marker for more rapid progression of heart failure. The only biomarkers independently distinguishing HFpEF and HFrEF are syndecan 4 and TGF beta 1.
Authors: Rachel C Kelley; Lauren Betancourt; Andrea M Noriega; Suzanne C Brinson; Nuria Curbelo-Bermudez; Dongwoo Hahn; Ravi A Kumar; Eliza Balazic; Derek R Muscato; Terence E Ryan; Robbert J van der Pijl; Shengyi Shen; Coen A C Ottenheijm; Leonardo F Ferreira Journal: J Appl Physiol (1985) Date: 2021-11-18
Authors: Thanh Thanh L Nguyen; Min Wang; Duan Liu; Seethalakshmi Iyer; Hilda Mariana Gonzalez Bonilla; Nancy Acker; Vishakantha Murthy; Sanskriti Shrivastava; Viral Desai; John C Burnett; Margaret Redfield; Kent R Bailey; Richard M Weinshilboum; Naveen L Pereira Journal: Circ Heart Fail Date: 2022-06-03 Impact factor: 10.447
Authors: Sven Persoon; Michael Paulus; Stephan Hirt; Carsten Jungbauer; Alexander Dietl; Andreas Luchner; Christof Schmid; Lars S Maier; Christoph Birner Journal: Heart Vessels Date: 2018-03-15 Impact factor: 2.037
Authors: Grażyna T Truszkowska; Zofia T Bilińska; Angelika Muchowicz; Agnieszka Pollak; Anna Biernacka; Katarzyna Kozar-Kamińska; Piotr Stawiński; Piotr Gasperowicz; Joanna Kosińska; Tomasz Zieliński; Rafał Płoski Journal: Sci Rep Date: 2017-06-13 Impact factor: 4.379
Authors: Honghuang Lin; Martina Mueller-Nurasyid; Albert V Smith; Dan E Arking; John Barnard; Traci M Bartz; Kathryn L Lunetta; Kurt Lohman; Marcus E Kleber; Steven A Lubitz; Bastiaan Geelhoed; Stella Trompet; Maartje N Niemeijer; Tim Kacprowski; Daniel I Chasman; Derek Klarin; Moritz F Sinner; Melanie Waldenberger; Thomas Meitinger; Tamara B Harris; Lenore J Launer; Elsayed Z Soliman; Lin Y Chen; Jonathan D Smith; David R Van Wagoner; Jerome I Rotter; Bruce M Psaty; Zhijun Xie; Audrey E Hendricks; Jingzhong Ding; Graciela E Delgado; Niek Verweij; Pim van der Harst; Peter W Macfarlane; Ian Ford; Albert Hofman; André Uitterlinden; Jan Heeringa; Oscar H Franco; Jan A Kors; Stefan Weiss; Henry Völzke; Lynda M Rose; Pradeep Natarajan; Sekar Kathiresan; Stefan Kääb; Vilmundur Gudnason; Alvaro Alonso; Mina K Chung; Susan R Heckbert; Emelia J Benjamin; Yongmei Liu; Winfried März; Michiel Rienstra; J Wouter Jukema; Bruno H Stricker; Marcus Dörr; Christine M Albert; Patrick T Ellinor Journal: Sci Rep Date: 2016-11-08 Impact factor: 4.379